Form 4: Protagonist Therapeutics Chief Medical Officer Sells Shares to Cover Tax Obligations

Protagonist Therapeutics' Chief Medical Officer, Arturo Molina, sold a portion of his shares to cover tax obligations related to the settlement of restricted stock units.

Summary

• Arturo Molina, the Chief Medical Officer of Protagonist Therapeutics, sold 3,640 shares of common stock on January 16, 2025.
• The sales were executed to cover tax withholding obligations arising from the settlement of restricted stock units.
• The transactions resulted in a decrease in Molina's direct holdings of Protagonist Therapeutics common stock from 87,144 to 83,892 shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to tax obligations, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares to cover tax obligations are a common practice among executives at publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the executive, suggesting this is a routine tax-related transaction rather than a significant divestment.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Protagonist Therapeutics, Arturo Molina, Chief Medical Officer, stock sale, Form 4, restricted stock units, tax obligations, insider trading